STARS HPS COVID-19 or other high consequence infectious diseases - - PowerPoint PPT Presentation

STARS HPS

COVID-19 or other high consequence infectious diseases (HCID’s)

DISPATCH CALL

• IFT to a facility which is an approximately 30-minute flight
• The patient is a 65-year old male who is suffering hypoxemic

respiratory failure secondary to presumed infection with the novel coronavirus (SARS-CoV-2 which causes COVID-19)

• Fevers, chills, cough and a sore throat which has been

progressive over the past 2-3 days

• His GCS is currently 15 and his vitals are as follows:
• T 38; P 121; RR 40; BP 124/79; O2 sats –76% on room air

(94% on 15L by prongs AND 15L by NRB); BGL 7.6

DISPATCH CALL continued

• Initial VBG (on O2) from facility

– pH 7.45 – pCO2 39 – pO2 50 – HCO3 25 – TCO2 26 – sO2 80 – Lac 1.8

AMC arrival at Hospital

• Patient seems to have deteriorated

– GCS now 13-14 (E4, V4, M5-6) – Vitals: HR 125, BP 120/75, RR 30, SpO2 89% on 15L NP and 15L NRB – repeat VBG next slide

10

ISTAT Venous CG4+

12

7.20 40 34

• 5

18 19 60 5.9

.

LABORATORY RESULTS FROM HOSPITAL

• Hgb

143

• Plt

299

• WBC

10.6

• Lymph

0.7

• Glucose

7.6

• Na

130 ↓

• K

3.1 ↓

• Cl

94 ↓

• Creatinine 68
• Urea

5.4

• Troponin 10
• D-Dimer

1.17 ↑

10

.

11

ISTAT VENOUS CHEM 8+

13

7.6 5.4 68 0.45 149 21 131 3.1 94 1.09 20

DEBRIEFING

• What went well?
• What else happened?
• How did the team function?
• How will you apply what you learned to the

clinical setting?

14

TEACHING SLIDE

16

• 1. Donning/Doffing PPE
• 2. Communication with PPE
• 3. Airway management in a patient with a highly

infectious respiratory pathogen such as SARS-CoV-2 which causes COVID-19 Note: D-dimer often elevated in COVID-19 patients – this is used for prognostication and research purposes. Do not initiate PE work-up unless clinically indicated.